v3.26.1
Consolidated Schedule of Investments - Forward Contracts (Parenthetical)
€ in Thousands, £ in Thousands, $ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2026
USD ($)
Dec. 31, 2025
USD ($)
Mar. 31, 2026
GBP (£)
Mar. 31, 2026
CAD ($)
Mar. 31, 2026
EUR (€)
Dec. 31, 2025
GBP (£)
Dec. 31, 2025
EUR (€)
Schedule of Investments [Line Items]              
Notional Amount $ 5,837,989,000 $ 5,837,989,000          
Change in unrealized appreciation (depreciation) (18,526,000) [1] 86,535,000          
Open Swap Contract, Identifier [Axis]: Foreign currency forward contract 1              
Schedule of Investments [Line Items]              
Notional Amount   60,102,000       £ 45,425  
Change in unrealized appreciation (depreciation)   (1,103,000)          
Open Swap Contract, Identifier [Axis]: Foreign currency forward contract 2              
Schedule of Investments [Line Items]              
Notional Amount   67,274,000         € 58,000
Change in unrealized appreciation (depreciation)   945,000          
Open Swap Contract, Identifier [Axis]: Foreign currency forward contracts              
Schedule of Investments [Line Items]              
Change in unrealized appreciation (depreciation) 2,132,000 $ (158,000)          
Open Swap Contract, Identifier [Axis]: Foreign currency forward contracts 1              
Schedule of Investments [Line Items]              
Notional Amount 60,819,000   £ 45,425        
Change in unrealized appreciation (depreciation) 733,000            
Open Swap Contract, Identifier [Axis]: Foreign currency forward contracts 2              
Schedule of Investments [Line Items]              
Notional Amount 208,508,000     $ 286,242      
Change in unrealized appreciation (depreciation) 1,162,000            
Open Swap Contract, Identifier [Axis]: Foreign currency forward contracts 3              
Schedule of Investments [Line Items]              
Notional Amount 66,954,000       € 58,000    
Change in unrealized appreciation (depreciation) $ 237,000            
[1] Amounts are presented in accordance with Regulation S-X 17 CFR § 210.12-13C. Refer to “Note 7 — Derivative Instruments” for additional details on the Company’s interest rate swaps.